ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,851Medicare Part D Prescriptions Filled, Including Refills

Rank: 374 out of 2588

$577K Total Retail Price of All Prescriptions

Rank: 357 out of 2588

358 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,493 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
AMLODIPINE BESYLATE 359 267 1 4
HYDROCODONE-ACETAMINOPHEN 318 150 S3 2 7
SIMVASTATIN 316 255 3 1
LISINOPRIL 300 198 4 3
METOPROLOL SUCCINATE 274 186 5 12
FUROSEMIDE 248 191 6 5
HYDROCHLOROTHIAZIDE 246 164 7 13
OMEPRAZOLE 233 143 8 6
LEVOTHYROXINE SODIUM 230 144 9 2
WARFARIN SODIUM 224 190 10 10
METOPROLOL TARTRATE 218 172 11 9
METFORMIN HCL 167 111 12 8
ATORVASTATIN CALCIUM 165 80 13 11
ATENOLOL 136 82 14 14
NAPROXEN 128 87 15 95
CLONIDINE HCL 128 68 15 54
GABAPENTIN 121 92 17 18
POTASSIUM CHLORIDE 116 94 18 15
ZOLPIDEM TARTRATE 114 45 19 24
PRAVASTATIN SODIUM 112 90 20 16
DONEPEZIL HCL 106 96 21 22
GLIMEPIRIDE 90 79 22 39
GLIPIZIDE ER 85 49 23 73
TRAMADOL HCL 83 32 24 19
PREDNISONE 83 62 24 42
FAMOTIDINE 80 54 26 36
METFORMIN HCL ER 79 47 27 67
PANTOPRAZOLE SODIUM 77 72 28 28
NIFEDIPINE ER 77 66 28 59
GLIPIZIDE 76 51 30 44
CYMBALTA 74 0 31 70
LANTUS SOLOSTAR 71 35 32 93
HYDRALAZINE HCL 70 53 33 53
CLOPIDOGREL 70 45 33 30
CARVEDILOL 69 49 35 20
AZITHROMYCIN 66 34 36 45
LIPITOR 64 16 37 114
KLOR-CON M20 63 34 38 52
LOSARTAN POTASSIUM 63 37 38 17
CIPROFLOXACIN HCL 62 41 40 82
LOSARTAN-HYDROCHLOROTHIAZIDE 62 38 40 66
ACETAMINOPHEN-CODEINE 62 42 S3 40 80
SPIRIVA 62 50 40 56
DIOVAN 61 31 44 29
CRESTOR 61 19 44 25
CYCLOBENZAPRINE HCL 61 35 R 44 87
PROAIR HFA 58 35 47 50
ISOSORBIDE MONONITRATE ER 56 54 48 49
ENALAPRIL MALEATE 55 35 49 31
AMLODIPINE BESYLATE-BENAZEPRIL 52 25 50 76
PLAVIX 52 35 50 43
PEN NEEDLE 52 36 50 112
FLUTICASONE PROPIONATE 52 16 50 40
NAMENDA 51 51 54 32
TAMSULOSIN HCL 50 38 55 23
CITALOPRAM HBR 50 29 55 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.